ABEONA THERAPEUT. DL-01 Cash Flow Conversion Efficiency

Latest as of December 2025: -0.113x

ABEONA THERAPEUT. DL-01 cash flow conversion efficiency. Based on the latest financial reports, ABEONA THERAPEUT. DL-01 (PCJ) has a cash flow conversion efficiency ratio of -0.113x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-17.95 Million ≈ $-20.99 Million USD) by net assets (€159.22 Million ≈ $186.14 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of ABEONA THERAPEUT. DL-01 (2021–2025)

Cash flow conversion efficiency of ABEONA THERAPEUT. DL-01 from 2021 to 2025. This chart illustrates how ABEONA THERAPEUT. DL-01's cash flow conversion efficiency has evolved over time, based on yearly financial data. View ABEONA THERAPEUT. DL-01 stock price for real-time trading data and today's change.

ABEONA THERAPEUT. DL-01 Cash Flow Conversion Ratio Explained

ABEONA THERAPEUT. DL-01 cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

ABEONA THERAPEUT. DL-01 Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of ABEONA THERAPEUT. DL-01 ranked by their cash flow conversion efficiency. Also see ABEONA THERAPEUT. DL-01 market capitalisation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Hunan Baili Engineering Sci SHG:603959	-0.207x
Dishman Carbogen Amcis Limited NSE:DCAL	0.046x
European Wax Center Inc NASDAQ:EWCZ	0.165x
Los Andes Copper Limited V:LA	0.003x
Hangzhou Hopechart Iot Technology SHG:688288	0.038x
E Split Corp Class A TO:ENS	0.100x
Shenzhen Sine Electric Co. Ltd. A SHG:688395	0.031x
Beijing YJK Building Software Co.Ltd. SHE:300935	N/A

Annual Cash Flow Conversion Efficiency for ABEONA THERAPEUT. DL-01 (2021–2025)

The table below shows the annual cash flow conversion efficiency of ABEONA THERAPEUT. DL-01 from 2021 to 2025. Review how financially flexible is ABEONA THERAPEUT. DL-01 to assess the company's free cash flow relative to its total liabilities.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	€159.22 Million ≈ $186.14 Million	€-76.33 Million ≈ $-89.23 Million	-0.479x	+62.32%
2024-12-31	€44.03 Million ≈ $51.48 Million	€-56.02 Million ≈ $-65.49 Million	-1.272x	+49.04%
2023-12-31	€14.83 Million ≈ $17.33 Million	€-37.01 Million ≈ $-43.27 Million	-2.496x	-53.63%
2022-12-31	€26.76 Million ≈ $31.29 Million	€-43.48 Million ≈ $-50.84 Million	-1.625x	-4.84%
2021-12-31	€42.37 Million ≈ $49.53 Million	€-65.67 Million ≈ $-76.77 Million	-1.550x	--

About ABEONA THERAPEUT. DL-01

F:PCJ Germany Biotechnology

Market Cap

$256.10 Million

€219.05 Million EUR

Market Cap Rank

#15288 Global

#1499 in Germany

Share Price

€3.85

Change (1 day)

-3.89%

52-Week Range

€3.56 - €6.36

All Time High

€17.73